VIT in Medical Technology

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

...he sustained delivery of medicines for retinal and vitreous diseases, according to a new report by A. Li...hrough the sclera, where it reaches the retina and vitreous. The device is so small the patient should f...equire frequent out-patient visits and can lead to vitreous hemorrhage and retinal detachment. Eye drops...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

...ew medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amg e n.com . Forward-Looking Statements This news release contains forward-looking statements that are based ...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... patients underwent four weeks of pretreatment with standard regional supplementation requirements for osteoporosis of not less than 400 IU per day of vitamin D and not less than 500 mg per day of calcium, which continued throughout the study. Treatment was randomized to Forteo(R) or one of three doses ...

Study Shows Brain Fitness can Save Medicare Billions

... The report is part of a multi-site trial funded by the National Institutes of Health and known as the Advanced Cognitive Training for Independent and vital Elderly (ACTIVE) study. There were 2,802 healthy adults, aged 65 and older, enrolled in the study. The participants were divided into three interve...

Scientists Discover Origin of Malaria

...n can last not just for decades, but millennia or more," Wolfe said. "This makes the task of stopping future disease spillovers from animals to humans vital, not only for saving lives today, but for the health of people for many generations to come." Every year malaria: Accounts for ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

...new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com. Forward-Looking Statements This news release contains forward-looking statements that are based on man...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

...es including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer...

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

...CV infection. PSI-7851 has demonstrated potent in vitro anti-HCV activity with EC(90) values of 31 +/-...e inhibitor, RG7128 (formerly known as R7128). In vitro studies of PSI-7851 have not shown evidence of...SI-7851 has demonstrated pan genotype activity in vitro . About Pharmasset Pharmasset is a ...

VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE

...ay using an integrated and innovative array of in vitro readouts and advanced in vivo imaging techno...the use of a series of advanced and integrated in vitro assays, microscopic readouts, and in vivo im... the heart." "We see the integration of in vitro and in vivo readouts becoming increasingly i...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

...ailed analysis of eight different domains including: physical functioning, role limitations because of physical problems, bodily pain, general health, vitality, social functioning, role limitations because of emotional problems and mental health. These scores were then compared to the scores of ...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

...new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com . About the Survey The survey was conducted online between March 25 and April 1, 2009, by Harris Interacti...

Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture

...air care and styling aids. Dove is available nationwide in food, drug and mass outlet stores. About Unilever Unilever's mission is to add vitality to life. We meet everyday needs for nutrition, hygiene and personal care with brands that help people feel good, look good and get more out of l...

NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study

...oduct pipeline includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo and is currently seeking development partners for these programs. Safe Harbor Statement This press release co...

July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals

...es the term "qi" (chee), which means life force or vital energy, and "gong" (kung), meaning accomplishme...se approaches, they may be worth a try. vitamins and Minerals from A to Zinc Are you getting enough (or too) much of important vit amins? ROCHESTER, Minn. --...

International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit

...enhancing images obtained on the 64-slice high resolution CT scan using the vitrea(R) imaging software program by vital Images. By using this imaging approach, Dr. Harbut was able to demonstra...

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

... are currently using drug combinations against NSCLC and head and neck cancers in two separate U.S. Phase II studies." The investigators examined in vitro combination effects of reovirus alone and in combination with cisplatin, gemcitabine or vinblastine. When reovirus was used alone, it demonstrated ...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

...isorders. As a part of the Association's research program, ICAD 2009 serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community. ICAD 2009 will be held in Vienna, Austria at Messe Wien Exhibition and Congress Center from July 11-16. The...

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

...s the blood-brain barrier has generated much interest in exploring its potential activity in the treatment of patients with advanced brain tumors. In vitro and in vivo data presented at AACR 2009 by investigators from the National Cancer Institute demonstrated that single agent perifosine not only indu...

GNC Unveils Study Results for First and Only Nitric Oxide Product Clinically Proven to Improve Physical Performance at NSCA Conference in Las Vegas

...titive athlete. About GNC GNC, headquartered in Pittsburgh, Pa., is the largest global specialty retailer of nutritional products including vitamin, mineral, herbal and other specialty supplements and sports nutrition, diet and energy products. As of March 31, 2009, GNC has more than 5,200 r...

Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharma's Product Class

...esis machinery found in all organisms, but human synthetases have naturally occurring resected variants with potent cell signaling activities that are vital to normal functioning of humans. aTyr Pharma's proprietary product generating engine consists of these resect ed prote ins ( resectins ) of hum...

PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it

...isorders. As a part of the Association's research program, ICAD 2009 serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community. ICAD 2009 will be held in Vienna, Austria at Messe Wien Exhibition and CongressCenter from July 11-16. Ab...

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

...isorders. As a part of the Association's research program, ICAD 2009 serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community. ICAD 2009 will be held in Vienna, Austria at Messe Wien Exhibition and CongressCenter from July 11-16. Ab...

FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)

...lm, President of Eisai Inc. "This application is one part of a full complement of clinical development programs we have committed for Dacogen and is a vital part of our human health care mission of increasing patient benefits and fulfilling unmet medical needs." Acceptance of the sNDA means that ...

Mayo Clinic Proceedings: A Comprehensive Review of Addiction to Prescription Painkillers Among Patients and Physicians

...in methods of drug delivery; increased public awareness of pain management options and the appropriateness of aggressively treating pain as the "fifth vital sign" and pain relief as a fundamental human right; growing recognition of the serious consequences of opioid misuse, misadventure and addiction; a...

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases

...new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com . Forward-Looking Statements This news release contains forward-looking statements that are based on man...

Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis

...es including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer...

ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402

...pment for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioIn...

Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections

...XA-101 in patients with complicated urinary tract infections. CXA-101 is a new broad-spectrum, parenteral cephalosporin antibiotic with excellent in vitro and in vivo activity against Pseudomonas aeruginosa , including drug resistant isolates. Calixa is investigating CXA-101 as a potential treatm...

New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF

... year's European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in vitro fertilisation (IVF) treatment MENOPUR (highly-purified human menopausal gonatropin or HP-hMG) offered considerable cost-savings over recombinant fo...

Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications

...ynthesis machinery found in all organisms, human synthetases have naturally occurring resected variants with potent cell signaling activities that are vital to normal functioning of humans. The work at Pangu BioPharma is focused on identifying and characterizing new examples of the tRNA synthetases res...

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)

...n that can be very difficult to manage and the availability of eslicarbazepine acetate adds an important new choice of therapy for patients who are in vital need of better seizure control." Epilepsy is one of the most common neurological diseases, affecting approximately one in 100 people6. Treat...

/C O R R E C T I O N -- Agendia B.V./

.... The FDA-cleared assay is always clinically useful and indicates whether a patient is at low or high risk for metastasis and the resulting clarity is vital in helping physicians personalize treatment options. "St. Gallen's guideline inclusion is a key step in further establishing MammaPrint as a...

Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

..., the Foundation has 80 chapters and branch offices, and supports and accredits a nationwide network of 110 CF care centers that provide treatment and vital resources to patients and families. For more information, visit www.cff.org . About PARI Pharma and the eFlow (R) Nebulizer Syste...

ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule

... which is in Phase III trials for the treatment of vitreomacular adhesion, is progressing according to s...smin trials is the non-surgical treatment of focal vitreomacular adhesion. Focal vit reomacular adhesion is a condition in which the...

Agendia's Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations

.... The FDA-cleared assay is always clinically useful and indicates whether a patient is at low or high risk for metastasis and the resulting clarity is vital in helping physicians personalize treatment options. "St. Gallen's guideline inclusion is a key step in further establishing MammaPrint as a...

Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug

...mprove Outcome of Intrauterine Insemination and In vitro Fertilization Procedures LA JOLLA, Calif.,... a novel ATP-based drug candidate designed for in vitro (outside of the human body) treatment of sperm...ction with intrauterine insemination (IUI) and in vitro fertilization (IVF) procedures. ATPotent(TM) i...

Alfacell Provides Shareholder Update

... to platinum increased tumor growth inhibition from 37% to 73%. These in vitro and in vivo data, which are presently being prepared for publication ...Another independent study in vivo is underway that may confirm Dr. Pass' in vitro study. After much thought, consideration, and input from highly re...

EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health

...tives segment. They range from amino acids and antioxidants to flavors and colorants to probiotics and enzymes. LAH also offers the entire spectrum of vitamins and provitamins, including beta-carotene, as well as specialties such as L-carnitine and botanicals. For more information, please visit ...

HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study

...lution and a cell preparation containing a mixture of growth arrested, living, allogeneic epidermal keratinocytes and dermal fibroblasts. Based on in vitro studies, HP802-247 is expected to release various growth and angiogenic factors into the microenvironment of the wound through administration of t...

CRi Oosight(TM) Instrument Crucial in IVF Breakthrough Demonstrating a Correlation Between Non-Invasive Egg Metrics and Pregnancy

...ounced today that Oosight(TM), a non-invasive optical imaging system manufactured by CRi and widely used by embryologists as an aid in the field of in vitro fertilization (IVF), has been used in a groundbreaking study that investigated ways to select eggs most likely to produce a pregnancy. Dr. Su...